Patents by Inventor Song Li

Song Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9457008
    Abstract: The present invention provides a joint product comprising synephrine and topiramate, in which the synephrine or salt thereof is administered in form of rapid-release preparation, preferably rapid-release pellet, having daily dose of 2 mg to 25 mg, preferably 5 mg to 20 mg; the topiramate is administered in form of sustained-release or controlled-release preparation, preferably sustained-release pellet, having daily dose of 20 mg to 100 mg, preferably 23 mg to 92 mg. The composition is used for treatment of obesity or other diseases associated with obesity.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: October 4, 2016
    Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Song Li, Chunsheng Gao, Wu Zhong, Yuli Wang, Meiyan Yang, Li Shan, Xinbo Zhou, Zhibing Zheng, Xiaokui Wang
  • Patent number: 9439881
    Abstract: The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: September 13, 2016
    Assignee: CHINESE PLA GENERAL HOSPITAL
    Inventors: Kunlun He, Song Li, Wu Zhong, Juan Liu, Lili Wang, Xin Li, Guoliang Hu, Jie Wang, Long Long, Junhai Xiao, Zhibing Zheng, Wei Li, Ruijun Li, Chunlei Liu, Jie Tang
  • Publication number: 20160254574
    Abstract: A universal rechargeable battery constituted by employing a lithium-ion battery and a control method for the rechargeable battery are provided. The rechargeable battery includes: an outer packaging housing and, sequentially laminated and assembled within the outer packaging housing, a charging/discharging controller, a positive electrode crimping piece, a lithium-ion battery, and a negative electrode end cap. The charging/discharging controller includes: a charging/discharging controller housing and, arranged within the charging/discharging controller housing, a charging/discharging control circuit solder body, an insulating washer, and a charging/discharging controller support frame. The charging/discharging control circuit solder body is soldered to a lithium battery charging/discharging control circuit.
    Type: Application
    Filed: December 9, 2014
    Publication date: September 1, 2016
    Applicant: SHENZHEN MAIGESONG ELECTRICAL TECHNOLOGY CO. LTD
    Inventor: SONG LI
  • Patent number: 9428496
    Abstract: Disclosed is as a substituted thiazolamine derivative represented by Formula I or a pharmaceutically acceptable salt thereof or a hydrate thereof (the definitions of each group in the formula are as presented in the description), and the application thereof in the prevention and/or treatment of viral diseases induced by picornavirus. Also disclosed is a pharmaceutical composition containing the compound.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: August 30, 2016
    Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Song Li, Hongliang Wang, Junhai Xiao, Xian Zhang, Lili Wang, Zhibing Zheng, Wu Zhong, Yunde Xie, Xingzhou Li, Xinbo Zhou, Guoming Zhao, Xiaokui Wang
  • Patent number: 9421188
    Abstract: The present invention provides a combination product, which comprises immediate release pellet of phentermine and sustained-release pellet of topiramate, wherein the pellet of topiramate includes: a) a blank pellet core; b) an active drug layer that contains topiramate and is free of binding agent, the layer being located on surface of the blank pellet core; c) a sustained-release coating layer containing ethyl cellulose and PVP K30, the sustained-release coating layer being located on external of the active drug layer. The present invention further discloses a method for preparing the combination product.
    Type: Grant
    Filed: March 20, 2013
    Date of Patent: August 23, 2016
    Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Song Li, Chunsheng Gao, Wu Zhong, Yuli Wang, Meiyan Yang, Li Shan, Xinbo Zhou, Zhibing Zheng, Xiaokui Wang
  • Publication number: 20160240592
    Abstract: An Organic Light Emitting Diode (OLED) display device and a manufacturing method thereof, the OLED display device including: a substrate; a pixel definition layer located on the substrate, wherein a plurality of pixel units arranged together are defined in the pixel definition layer, at least one of the pixel units comprises at least one first sub pixel, at least one second sub pixel and at least one third sub pixel, and the third sub pixel comprises at least two third secondary sub pixels; a first organic light emitting layer arranged in each of the at least one first sub pixel, a second organic light emitting layer arranged in each of the at least one second sub pixel, and third organic light emitting layers arranged in the at least two third secondary sub pixels of the at least one third sub pixel.
    Type: Application
    Filed: June 26, 2015
    Publication date: August 18, 2016
    Inventors: Song Li, Sheng Huang, Ning Yu, Liyuan Luo, Bojia Lv
  • Patent number: 9410364
    Abstract: A sealed magnetic-controlled window blind between two panes of glass is disclosed. Raising or lowering the window blind which is sealed between two panes of glass is performed by the magnetic attraction between the between the raising outside control set and the raising inside control set (the magnets may be used). In addition, the operation of raising or lowering the window blind may be smooth due to the arrangement of the pulleys (or bearing) which are arranged on the raising inside control set and the outside control set.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: August 9, 2016
    Assignee: Supreme Plastic Products Co., Ltd.
    Inventor: Song-Li Zheng
  • Publication number: 20160223738
    Abstract: A back plate, a method for manufacturing the back plate and a backlight module are provided. The method for manufacturing the back plate includes the following steps. A main body is provided. The main body includes a bottom portion and at least one sidewall connected to the bottom portion. The sidewall has a plurality of grooves, and each of the grooves has a first side surface and a second side surface. A first recess and a second recess corresponding to the first recess are respectively disposed on the first side surface and the second side surface. An external force is applied on the bottom portion to form each of the bottom portion and the sidewalls into arc shape, in which the first side surface contacts the second side surface of each groove, and a hole portion is formed between the first recess and the second recess.
    Type: Application
    Filed: April 20, 2015
    Publication date: August 4, 2016
    Inventors: Tsung-Hsin LIU, Qing-Song LI, Chih-Ming CHAN
  • Publication number: 20160190355
    Abstract: An auto-adjusting device for adjusting a drive voltage of a light receiver includes an amplifier, an analog-to-digital converter, a determination control circuit and a boost circuit. The amplifier is configured to amplify an analog signal generated by the light receiver. The analog-to-digital converter is configured to convert the amplified analog signal to a digital signal. The determination control circuit is configured to process and determine the digital signal, and output a control signal when the processed digital signal satisfies a predetermined condition. The boost circuit is configured to receive the control signal and adjust the drive voltage of the light receiver.
    Type: Application
    Filed: December 28, 2015
    Publication date: June 30, 2016
    Inventors: Song Li, Qi Lan
  • Publication number: 20160188312
    Abstract: The subject matter described herein relates to application installation/uninstallation across multiple systems. Responsive to installation or uninstallation of an application on a first system running on a device, it is determined whether the application is to be installed or uninstalled on a second system. Responsive to determining that the application is to be installed or uninstalled on the second system, an indication is set while the first system is running, where the indication causes installation or uninstallation of the application on the second system.
    Type: Application
    Filed: January 28, 2015
    Publication date: June 30, 2016
    Inventors: Xiaolong Shi, Song Li
  • Patent number: 9377511
    Abstract: Methods and devices applying to a clock system of scan circuits to enhance the test coverage for structural delay-fault tests are provided. According to an aspect, a method applying to a clock system of a scan circuit of a scan test containing one or more clock gating cells includes at any stage of the scan test outputting a controllable waveform of a clock signal at each clock gating cell, and eliminating a partially enabled clock signal during a capture cycle at each clock gating cell.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: June 28, 2016
    Assignee: Infineon Technologies AG
    Inventor: Zhen Song Li
  • Patent number: 9359314
    Abstract: The present invention relates to a thiazine amide derivative and a pharmaceutical use thereof, and particularly to a compound of formula I (in the formula, variables are as described in the specification), a pharmaceutically acceptable salt, solvate or hydrate thereof. The present invention further relates to a method for preparing the compound, a pharmaceutical composition containing the compound, and a method or use thereof for prevention or treatment of neurodegenerative diseases.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: June 7, 2016
    Assignee: Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
    Inventors: Song Li, Junhai Xiao, Dan Han, Wu Zhong, Lili Wang, Zhibing Zheng, Yunde Xie, Xinbo Zhou, Xingzhou Li, Xiaokui Wang, Dan Jiang, Wei Chen, Hongying Liu
  • Patent number: 9350361
    Abstract: A clock signal generating circuit includes a crystal oscillator, a phase compensation circuit, a negative resistance compensation circuit, and a high pass filter circuit. The crystal oscillator generates a clock signal. The phase compensation circuit compensates a phase of the clock signal. The negative resistance compensation circuit filters phase noises of the clock signal. The high pass filter circuit filters low frequency noises of the clock signal.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: May 24, 2016
    Assignees: HONG FU JIN PRECISION INDUSTRY (ShenZhen) CO., LTD., HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: Jin-Song Li, Wei Pan
  • Publication number: 20160141563
    Abstract: The present application relates to the field of energy storage devices, in particular to a lithium secondary battery.
    Type: Application
    Filed: November 17, 2015
    Publication date: May 19, 2016
    Inventors: Minmin Zou, Song Li, Dengjun Ai
  • Publication number: 20160137619
    Abstract: The present invention pertains to field of pharmaceutical chemicals, and relates to thiazole inner salt compounds, preparation methods and uses thereof. Specifically, the present invention relates to a compound of Formula I, hydrates or pharmaceutically acceptable salts thereof. The compound of Formula I of the present invention is a potent cross-linking protein cleavage agent, has a stable structure, good physical and chemical properties, and good pharmacological activities, and is suitable for large scale production to obtain samples with stable, controllable and reliable quality, thereby being suitable for pharmaceutical development.
    Type: Application
    Filed: July 9, 2014
    Publication date: May 19, 2016
    Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Song LI, Wu ZHONG, Shuang CAO, Lili WANG, Zhibing ZHENG, Junhai XIAO, Xinbo ZHOU
  • Publication number: 20160128938
    Abstract: A method of creating a formulation for a compound includes determining a compound interactive agent comprising at least one group that interacts with the compound, creating a carrier agent by conjugating at least one compound interactive domain comprising the at least one group that interacts with the compound with at least one hydrophilic domain, and combining the compound and the carrier agent to create the formulation. Creating the carrier agent may further include conjugating the at least one compound interactive domain with at least one hydrophobic domain so that the at least one compound interactive domain is positioned between the at least one hydrophilic domain and the at least one hydrophobic domain.
    Type: Application
    Filed: December 12, 2013
    Publication date: May 12, 2016
    Inventors: Xiang Gao, Song Li, Peter Wipf, Michael Wayne Epperly, Joel S. Greenberger
  • Publication number: 20160115160
    Abstract: Provided are a compound of formula I which can be used as a drug against small RNA virus infections, and optical isomers, pharmaceutically acceptable salts, solvates or hydrates thereof. Also provided are the preparation method of the compound, the method for using the compound for treating bacterial infections and the use of the compound in the preparation of a drug for preventing and/or treating viral diseases caused by small RNA viruses.
    Type: Application
    Filed: May 28, 2014
    Publication date: April 28, 2016
    Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Song LI, Junhai XIAO, Xian ZHANG, Wu ZHONG, Zhibing ZHENG, Lili WANG, Yunde XIE, Xingzhou LI, Xinbo ZHOU, Xiaokui WANG
  • Publication number: 20160117983
    Abstract: A circuit is disclosed. The circuit includes a first transistor, to respond to a first scanning signal and to transmit a first voltage, a first capacitor, to store the first voltage, and an organic light emitting diode. The circuit also includes a second transistor, to provide a current to the organic light emitting diode, a third transistor, to respond to a second scanning signal and to transmit a first potential signal to the second transistor, and a fourth transistor, to respond to the first scanning signal and to form a diode connection of the second transistor. The circuit also includes a fifth transistor, to respond to a third scanning signal and to transmit a second signal voltage to the second transistor, and a sixth transistor, to respond to a light emitting scanning signal, and to output the current to the organic light emitting diode.
    Type: Application
    Filed: July 16, 2015
    Publication date: April 28, 2016
    Inventors: Song Li, Liyuan Luo, Gang Liu
  • Patent number: 9272992
    Abstract: The present invention relates to (1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentyl-1-carboxylic acid hydrates compounds, preparing methods thereof, pharmaceutical compositions containing said compounds and preparing methods thereof, and the clinical uses of said compounds as neuramidinase inhibitors for anti-influenza.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: March 1, 2016
    Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A., China
    Inventors: Song Li, Wu Zhong, Zhibing Zheng, Xinbo Zhou, Junhai Xiao, Yunde Xie, Lili Wang, Xingzhou Li, Guoming Zhao, Xiaokui Wang, Hongying Liu
  • Patent number: 9277280
    Abstract: The invention discloses a method for controlling digital film play-count and a system thereof, wherein a play-count parameter is added into a KDM file where a key delivery message used for controlling film play is embedded, detecting the play-count parameter for a playing film, setting RSA key abstracts of an FDM packager of all authorized contracting film producers, safely importing the KDM and play-count into a security module, detecting the play-count parameter for a playing film. The film is not permitted to play unless existing play-count is less than the authorized play-count in the FDM. The invention fulfills the requirements and demands for controlling the distribution and playback of digital films in the second-tier market using technologies such as the authorized play-count and a method to charge on the basis of play-count.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: March 1, 2016
    Assignee: GDC Technology (Shenzhen) Limited
    Inventors: Man Nang Chong, Pranay Kumar, Sam Chiu, Jin Song Li